Andrew Clark

Andrew Clark has a diverse work experience spanning over several companies. Andrew currently holds the position of Vice President, Group Chief Financial Officer and Finance M&A (Product Quality and Innovation) at Veralto since October 2023. Prior to this, they have held various senior roles at Danaher Corporation, including Danaher Vice President, Group Chief Financial Officer and Finance M&A, Product Identification from July 2023 to October 2023, and Danaher Vice President and Group Chief Financial Officer, Genomic Medicines Group from October 2021 to July 2023. Andrew has also served as CFO / Global Vice President Finance, IT & Operations (Life Sciences - SCIEX) from October 2017 to October 2021, CFO/Vice President Finance & IT (Life Sciences - SCIEX) from August 2012 to October 2017, and Vice President Finance / CFO (Industrial Technologies - Portescap, Setra, Sonix) from May 2008 to August 2012. Prior to joining Danaher Corporation, Andrew worked as CFO at CEG, Inc. from May 2007 to May 2008, Director of Accounting at PGT Industries from July 2006 to May 2007, CFO at The Gemesis Corporation from 2004 to 2006, Vice President Finance & Administration at Peek Traffic Corporation from 2000 to 2004, Corporate Controller at Thermo Fisher Scientific from October 1998 to December 2000, and Manager, Audit Advisory Services at Price Waterhouse Coopers from 1992 to 1998.

Andrew Clark earned a Bachelor of Science (BS) degree in Accounting from the University of Connecticut School of Business between 1988 and 1992. Andrew also obtained a Bachelor of Science (B.S.) degree in Business Administration and Management, General from the same school during the same period. Andrew Clark holds a certification as a Certified Public Accountant.